Posts filtered by tags: Gilead[x]


 

Coronavirus US: Biden tells Trump 'step up and do your job' over Covid-19 death toll – live

Negotiations on bailout package expected to resume in WashingtonTrump visibly struggles to defend Covid-19 record in Axios interviewJoin us for an online event with Eric Holder to discuss voter suppression in the 2020 election, Thursday at 5pm ET. Register nowSign up to our First Thing newsletter 2.28pm BST “It didn’t have to be this way,” the Democratic National Committee says of Trump’s trainwreck Axios/ HBO interview. Here’s the full DNC statement:Trump’s disastrous interview would be lau...
Tags: Eric Holder, US, Dnc, World news, Joe Biden, US news, US politics, Biden, Donald Trump, Trump, Martin, Gilead Sciences, Tom McCarthy, Democratic National Committee, Public Citizen, Gilead


Covid-19 treatment: Gilead Sciences urged to study drug that showed promise with cats

Activists accuse company of pushing remdesivir to boost profitGS-441524 has been used to treat a coronavirus in catsCoronavirus – latest global updatesActivists are calling on the pharmaceutical firm Gilead Sciences to study a drug for the treatment of Covid-19 that showed promise in curing cats of a coronavirus.The drug, called GS-441524, is chemically related to remdesivir, an antiviral also made by Gilead, and one of the only treatments to successfully shorten the duration of Covid-19 recover...
Tags: Business, Science, US news, Infectious Diseases, Pharmaceuticals industry, Gilead Sciences, Gilead, Coronavirus outbreak


Covid-19: Gilead Sciences urged to study drug that showed promise with cats

Activists accuse company of pushing remdesivir to boost profitGS-441524 has been used to treat a coronavirus in catsCoronavirus – latest global updatesActivists are calling on the pharmaceutical firm Gilead Sciences to study a drug for the treatment of Covid-19 that showed promise in curing cats of a coronavirus.The drug, called GS-441524, is chemically related to remdesivir, an antiviral also made by Gilead, and one of the only treatments to successfully shorten the duration of Covid-19 recover...
Tags: Business, Science, US news, Infectious Diseases, Pharmaceuticals industry, Gilead Sciences, Gilead, Coronavirus outbreak


Intel: Putin’s Hillary Hackers Now After Our COVID-19 Vaccine Secrets

A Russian hacking group that played a role in breaking into Democratic networks during the 2016 election is now trying to steal coronavirus research, according to officials in the U.S., U.K., and Canada.  In a joint cybersecurity advisory released by the three countries, intelligence agencies warned that a Russian hacking ground referred to as “APT29” had “targeted various organisations involved in COVID-19 vaccine development in Canada, the United States and the United Kingdom, highly likely wi...
Tags: Google, News, Putin, Nsa, China, Russia, Merck, Ukraine, Intel, Fbi, Canada, Britain, United States, United Kingdom, Moscow, Fireeye


HHS allocates Gilead's COVID-19 drug remdesivir to four hardest hit states

The remdesivir is being distributed to Texas, Florida, California and Arizona on Friday and Monday, according to a U.S. Department of Health and Human Services (HHS) website https://www.phe.gov/emergency/events/COVID19/investigation-MCM/Pages/commercial-allocation-table.aspx. Remdesivir is in high demand as one of the only treatments so far shown to alter the course of COVID-19. After the intravenously administered medicine helped shorten hospital recovery times in a clinical trial, it won em...
Tags: News, United States, Arizona, HHS, Gilead, U S Department of Health and Human Services HHS, COVID, Texas Florida California


Remdesivir and COVID-19: New data suggests the experimental drug can shorten how long people are sick

According to new results from Gilead, new data shows 74% of patients treated with remdesivir had recovered by their 14th day of hospitalization.         [Author: USA TODAY]
Tags: Usa, News, Usa Today, Gilead


Stocks battle higher as coronavirus treatment shows promise

A study found Gilead Science's drug remdesivir reduced the risk of death for COVID-19 patients by 62 percent.
Tags: Finance, Article, FBN, Gilead, Fbn/markets, FOXBusiness, Fox-business/markets/stocks, Fox-business/markets/earnings, Fox-business/markets/us-markets, Jonathan Garber, Fox-business/topic/coronavirus, E147ceb5-707d-5871-bb0b-12bca1acfda8


Gilead analysis shows remdesivir reduced coronavirus death risk, more studies needed

Remdesivir has been at the forefront of the global battle against COVID-19 after the intravenously administered medicine helped shorten hospital recovery times, according to data in April from a separate U.S. government trial. In the latest analysis, Gilead said it analyzed data from 312 patients treated in its late-stage study and a separate real-world retrospective cohort of 818 patients with similar characteristics and disease severity. Gilead's late-stage study evaluated the safety and eff...
Tags: News, Gilead, COVID, Remdesivir




Gilead to deliver more remdesivir to Germany, Europe from the Fall - WiWo

Gilead Sciences Inc plans to make more of its drug remdesivir available for Germany and Europe from the Fall and will decide how much each country gets based on the rate of infection, the drugmaker's Germany boss told a German magazine. Bettina Bauer, German managing director of Gilead, told WirtschaftsWoche the U.S. drugmaker can increase its worldwide monthly production from currently 190,000 treatment cycles to two million treatment cycles in December. Remdesivir is currently the only ...
Tags: Europe, News, Germany, Eu, Gilead Sciences Inc, Gilead, Wirtschaftswoche, Germany Europe, Bettina Bauer German


Gilead begins testing inhalable form of remdesivir for COVID-19

The company said the trial, which will enroll about 60 healthy Americans aged between 18 and 45, will test the drug particularly in those cases where the disease has not progressed to require hospitalization. The drug is currently used intravenously and an inhaled formulation would be given through a nebulizer, which could potentially allow for easier administration outside hospitals. Remdesivir was granted emergency use authorization in the United States to treat severe cases of COVID-19 in p...
Tags: News, United States, Gilead


GSK says long-acting HIV prevention drug 66% more effective than Truvada

HIV incidence rate - or the number of people who contract the infection in a period - was 0.41% with the injection, compared with 1.22% with Gilead's Truvada, final data from a study presented at the virtual AIDS conference showed. Truvada is currently the standard of care for preventing HIV, but GSK hopes to challenge its dominance by making shorter, long-lasting regimens and less toxic alternatives through its ViiV Healthcare unit. "This advancement has the potential to be a game-changer for...
Tags: News, Truvada, GSK, Gilead, ViiV Healthcare, Kimberly Smith


US Secures World Stock of Key COVID-19 Drug Remdesivir

The U.S. has bought up virtually all the stocks of remdesivir, perhaps the most closely watched experimental drug to treat COVID-19. The Guardian reports: Remdesivir, the first drug approved by licensing authorities in the U.S. to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of G...
Tags: Senate, US, Tech, Anthony Fauci, Trump, Gilead, Alex Azar


US gets almost all of the world's supply of key Covid-19 drug

The United States has been allocated almost all of pharmaceutical company Gilead's supply of remdesivir, the only drug known to work against Covid-19.
Tags: Health, US, United States, Gilead


Hong Kong is gone. It's over.

Hello, everyone! Welcome to the new edition of Insider Today. Please sign up here. QUOTE OF THE DAY "We are living in an Idiocracy." — Washington Post conservative columnist Max Boot bemoaning the stupidity of the Federal government's refusal to advocate ubiquitous mask wearing and thereby save 5% of GDP. WHAT'S HAPPENING Hong Kong police arrested more than 300 people protesting a new security law imposed by China. Police say nine arrests were under the new law, which criminalizes any spe...
Tags: Apple, Hong Kong, Florida, London, Obama, Congress, Colorado, Washington, Senate, White House, China, US, Trends, Georgia, Fbi, Harvard


Coronavirus: US buys nearly all of Gilead's Covid-19 drug remdesivir

The US will acquire almost all the next three months' production of the drug from Gilead.
Tags: News, US, Gilead


Coronavirus Australia update: Victoria reports 73 new Covid-19 cases as NSW announces $11,000 fines – live news

Residents of 10 postcodes in Melbourne’s north and west have been ordered to stay home from midnight tonight. Follow liveInside Melbourne’s hotspot suburbsEverything we know about Victoria’s clustersFollow the global coronavirus live blogDownload the Guardian app to get the most important news notifications 3.24am BST Associate Professor Barbara Mintzes from The University of Sydney Charles Perkins Centre and School of Pharmacy said if remdesivir does prove effective in treating Covid-19, th...
Tags: Health, Business, Australia, US, Australia news, Infectious Diseases, Pakistan, Coalition, Australian politics, Netherlands, Queensland, New South Wales, Queensland politics, Victorian politics, New South Wales politics, Victoria


Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

The pharmaceutical company behind a drug that’s been approved by the Food and Drug Administration for emergency use for covid-19 patients announced today the drug will cost $3,120 per typical treatment course for individuals with private insurance plans.Read more...
Tags: Science, Food And Drug Administration, Gilead, Coronavirus, Covid 19, Sars Cov 2, Remdesivir


Coronavirus drug price ‘an outrage’: $2,340 for remdesivir, or even more for those with private insurance

“We’re in uncharted territory with pricing a new medicine, a novel medicine, in a pandemic,” Gilead’s chief executive, Dan O’Day, told The Associated Press.
Tags: Gilead, Dan O'Day


Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations

The price tag is slightly below the range of $2,520 to $2,800 suggested last week by U.S. drug pricing research group the Institute for Clinical and Economic Review (ICER) after British researchers said they found that the cheap, widely available steroid dexamethasone significantly reduced mortality among severely ill COVID-19 patients. Remdesivir is expected to be in high demand as one of the only treatments so far shown to alter the course of COVID-19. After the intravenously administered me...
Tags: News, United States, Gilead, Institute for Clinical and Economic Review ICER


U.S. to ship remdesivir to states including California and Texas with rising COVID-19 cases

The U.S. government will ship more of Gilead Sciences Inc's antiviral treatment remdesivir to states experiencing an increase in COVID-19 cases including California, Texas, Florida and Arizona, according to the Department of Health and Human Services' website. The government reallocated remdesivir to states with increasing cases, White House task force coordinator Deborah Birx said during a briefing on Friday. HHS said on its website that the doses will ship starting Monday and extinguish th...
Tags: Texas, News, California, White House, Arizona, HHS, Department of Health and Human Services, Gilead Sciences Inc, Gilead, California Texas Florida, Deborah Birx


South Korea backs remdesivir for COVID-19, urges caution with dexamethasone

South Korea has added Gilead's anti-viral drug remdesivir to its coronavirus treatment guidelines in its first revision of recommendations since the outbreak began and urged caution in the use of the steroid therapy dexamethasone. Remdesivir is designed to hinder certain viruses, including the new coronavirus, from making copies of themselves and potentially overwhelming the body's immune system.
Tags: South Korea, News, Gilead


Trailer for Season Four of The Handmaid’s Tale

Season four of The Handmaid’s Tale is coming to Hulu in 2021. I found season 3 to be increasingly outlandish — not in terms of the depicted fascist policies and behaviors of Gilead (Atwood has stated that in her books & the TV series, all events have a precedent) but just in terms of “How the hell is June still alive and working in Gilead?!” Also, the use of closeups of Elisabeth Moss’s facial expressions to convey emotion was overused to the point of cliche. But I will definitely give seaso...
Tags: Margaret Atwood, Hulu, Elisabeth Moss, Jason Kottke, Gilead, Gilead Atwood


Gilead's remdesivir set to become Europe's first COVID-19 therapy

The European Medicines Agency (EMA) said on Thursday its human medicines committee (CHMP) recommended conditionally approving the drug for adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support. European Union conditional marketing authorisation allows a treatment to be sold for a year in the 27-nation bloc before all necessary data on its efficacy and side-effects are available. Gilead has until December to submit this data.
Tags: Europe, News, European Union, Gilead, European Medicines Agency EMA


‘The Handmaid’s Tale’ Season 4 Teaser: Change Never Comes Easy

“Change never comes easy,” June muses in The Handmaid’s Tale season 4 teaser, which feels like a bit of an understatement for the bleak, slow-moving dystopian Hulu series based on the novel by Margaret Atwood. But the plodding drama series promises the long-awaited revolution against the totalitarian regime of Gilead, though we will still have to wait until next year to see it play out. Watch The Handmaid’s Tale season 4 teaser below. The Handmaid’s Tale Season 4 Teaser Hulu has release...
Tags: Television, Movies, Drama, Sci-fi, United States, Adaptation, Margaret Atwood, Hulu, Elisabeth Moss, Moss, Lawrence, Ann Dowd, Lydia, Gilead, Bradley Whitford, TV Trailer


U.S. group raises pricing recommendation for Gilead's remdesivir in COVID-19

The Institute for Clinical and Economic Review (ICER) said its recommendation change stemmed from recent clinical data, updated cost estimates, public comments and interactions with Gilead. What Gilead could charge for remdesivir in the United States after its pledged donations are used up has been a topic of intense debate, with experts suggesting that Gilead would need to avoid the appearance of taking advantage of a health crisis for profits.
Tags: News, United States, Gilead, Institute for Clinical and Economic Review ICER


Gilead to Test a Version of Remdesivir That Can Be Inhaled

As scientists study the effectiveness of the drug against the coronavirus, others are exploring how to make the potential treatment easier to administer.
Tags: News, Food And Drug Administration, Steroids, Gilead Sciences Inc, Gilead, Northwell Health, Drugs (Pharmaceuticals, Your-feed-science, Your-feed-health, Coronavirus (2019-nCoV, Remdesivir (Drug


India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir

Indian drugmaker Zydus Cadila said on Friday it signed a non-exclusive licensing pact with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in COVID-19 trials.
Tags: Money, India, businessNews, Gilead Sciences Inc, Gilead, Zydus Cadila


Gilead and Kite to present data from cell therapy research at 25th EHA Virtual Congress

Gilead Sciences, Inc. and Kite, a Gilead Company, are pleased to support the Virtual Edition of the 25th European Hematology Association Annual Congress, taking place 11–21 June 2020.
Tags: Health, Kite, Gilead Sciences Inc, Gilead, Gilead Company, EHA Virtual Congress


Singapore approves Gilead's remdesivir for COVID-19 treatment

Singapore's Health Sciences Authority said on Wednesday it granted conditional approval for Gilead Sciences Inc's antiviral drug remdesivir for the treatment of some patients with COVID-19 infection.
Tags: Money, Singapore, businessNews, Gilead Sciences Inc, Gilead, Singapore s Health Sciences Authority